Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors.
Journal: Journal of virology
Published: May 18, 2023
Anti-tumor memory CD4 and CD8 T-cells quantified by bulk T-cell receptor (TCR) clonal analysis.
Journal: Frontiers in immunology
Published: January 03, 2023
Quantitative Electroencephalography (EEG) Predicting Acute Neurologic Deterioration in the Pediatric Intensive Care Unit: A Case Series.
Journal: Journal of child neurology
Published: November 24, 2021
Antitumor Memory T-Cells Become Functionally Mature from 30 to 100 days in a Mouse Model of Neoplasia.
Journal: Anticancer research
Published: October 18, 2017
Memory Antitumor T-Cells Resist Inhibition by Immune Suppressor Cells.
Journal: Anticancer research
Published: August 09, 2015
Viral infection of implanted meningeal tumors induces antitumor memory T-cells to travel to the brain and eliminate established tumors.
Journal: Neuro-oncology
Published: September 17, 2014
Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu.
Journal: International journal of cancer
Published: March 14, 2007
Preferential targeting of vesicular stomatitis virus to breast cancer cells.
Journal: Virology
Published: April 08, 2004
Vesicular stomatitis virus expressing a chimeric Sindbis glycoprotein containing an Fc antibody binding domain targets to Her2/neu overexpressing breast cancer cells.
Journal: Virology
Published: December 03, 2003
Showing 1-11 of 11
Last Updated: 09/26/2026